Changes in Body Fat Distribution on Dual-Energy X-Ray Absorptiometry in Black South Africans Starting First-Line Antiretroviral Therapy

被引:11
作者
Abrahams, Zulfa [1 ]
Levitt, Naomi [1 ]
Lesosky, Maia [2 ]
Maartens, Gary [3 ]
Dave, Joel [1 ]
机构
[1] Univ Cape Town, Div Diabet Med & Endocrinol, Dept Med, Cape Town, South Africa
[2] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa
[3] Univ Cape Town, Div Clin Pharmacol, Dept Med, Cape Town, South Africa
关键词
ART; lipodystrophy; lipoatrophy; lipohypertrophy; DEXA; RANDOMIZED-TRIAL; REGIMENS; COMBINATION; STAVUDINE; LIPODYSTROPHY; POPULATION; PREVALENCE; LAMIVUDINE; MORTALITY; RITONAVIR;
D O I
10.1089/apc.2016.0183
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Long-term use of antiretroviral therapy (ART) increases the risk of developing lipodystrophy. Few studies from Africa have used longitudinal data to assess the development of lipoatrophy and lipohypertrophy. We use clinical anthropometry and dual-energy X-ray absorptiometry (DEXA) to describe changes in body fat distribution over a 24-month period in individuals initiated on ART. A convenience sample of black South Africans (55 men and 132 women) were recruited and followed for 24 months after commencing ART. Body fat distribution was assessed using anthropometric measurements and DEXA scans at baseline and then at 3, 6, 12, 18, and 24 months after commencing ART. DEXA was also used to estimate abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). Women gained more overall weight and more regional fat in all areas analyzed on DEXA scans. Women, not men, experienced a significant increasing trend in trunk fat and a significant decreasing trend in limb fat, when expressed as a percentage of total body fat. In men, the risk of developing lipoatrophy was more than two times greater than that of women, after adjusting for age, baseline body mass index, and ART regimen. Lipohypertrophy occurred similarly in men and women. VAT and SAT increased significantly in men and women, with women gaining considerably more than men. These findings are of great concern as an increased waist circumference is associated with increased mortality in HIV-infected populations. Further investigation is required to understand the mechanisms underlying the sex differences in changes in body fat distribution and its effects on cardiovascular risk.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 29 条
[1]  
Abrahams Z, 2014, AIDS RES THER, V66, P839
[2]  
[Anonymous], 17 C RETR OPP INF FE
[3]  
[Anonymous], 2013, S AFR ANT TREATM GUI
[4]   Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial [J].
Bussmann, Hermann ;
Wester, C. William ;
Thomas, Ann ;
Novitsky, Vladimir ;
Okezie, Reginald ;
Muzenda, Tanaka ;
Gaolathe, Tendani ;
Ndwapi, Ndwapi ;
Mawoko, Norah ;
Widenfelt, Erik ;
Moyo, Sikhulile ;
Musonda, Rosemary ;
Mine, Madisa ;
Makhema, Joseph ;
Moffat, Howard ;
Essex, Max ;
DeGruttola, Victor ;
Marlink, Richard G. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (01) :37-46
[5]  
Carter V M, 2001, HIV Med, V2, P174, DOI 10.1046/j.1468-1293.2001.00073.x
[6]   Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy [J].
Casado, Jose L. ;
Iglesias, Veronica ;
del Palacio, Maria ;
Marin, Ana ;
Perez-Elias, Maria J. ;
Moreno, Ana ;
Moreno, Santiago .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2013, 25 (12) :1599-1603
[7]   Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction [J].
de Waal, Renee ;
Cohen, Karen ;
Maartens, Gary .
PLOS ONE, 2013, 8 (05)
[8]  
Devanathan R, 2013, AFR J PRIM HEALTH CA, V5, DOI 10.4102/phcfm.v5i1.450
[9]   Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides [J].
Dubé, MP ;
Parker, RA ;
Tebas, P ;
Grinspoon, SK ;
Zackin, RA ;
Robbins, GK ;
Roubenoff, R ;
Shafer, RW ;
Wininger, DA ;
Meyer, WA ;
Snyder, SW ;
Mulligan, K .
AIDS, 2005, 19 (16) :1807-1818
[10]   Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial [J].
Gallant, JE ;
Staszewski, S ;
Pozniak, AL ;
DeJesus, E ;
Suleiman, JMAH ;
Miller, MD ;
Coakley, DF ;
Lu, B ;
Toole, JJ ;
Cheng, AK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02) :191-201